Laboratory diagnosis of mucormycosis: current status and future perspectives
- PMID: 24957094
- DOI: 10.2217/fmb.14.23
Laboratory diagnosis of mucormycosis: current status and future perspectives
Abstract
Fungal infections caused by members of the Mucorales order are rapidly progressing and fatal. The importance of mucormycosis has grown in recent years as the number of patients with predisposing factors has increased dramatically. Clinical symptoms are elusive and conventional techniques are often insensitive and unspecific; in particular, cultures are often negative even though direct microscopy is positive. For early diagnosis of the causative agent of disease and subsequently guiding therapy to improving patients' outcome, molecular assays are promising add-ons. This article provides an overview on current laboratory methods for diagnosing mucormycosis with a special focus on new molecular-based tools. We aim to highlight the pros and cons of various techniques at hand. Given the increase in number and the severity of these infections, molecular approaches for improved diagnosis are highly warranted.
Keywords: PCR; internal transcribed spacer; matrix-assisted laser desorption ionization time of flight; molecular diagnosis; mucorales; mucormycosis; species identification.
Similar articles
-
Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism.J Clin Microbiol. 2006 Mar;44(3):805-10. doi: 10.1128/JCM.44.3.805-810.2006. J Clin Microbiol. 2006. PMID: 16517858 Free PMC article.
-
Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.Clin Infect Dis. 2013 May;56(10):e95-101. doi: 10.1093/cid/cit094. Epub 2013 Feb 18. Clin Infect Dis. 2013. PMID: 23420816
-
Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry.Clin Microbiol Infect. 2015 Jun;21(6):594.e1-5. doi: 10.1016/j.cmi.2015.01.017. Epub 2015 Jan 28. Clin Microbiol Infect. 2015. PMID: 25726039
-
[Laboratory diagnosis of mucormycosis].Med Sci (Paris). 2013 Mar;29 Spec No 1:13-8. doi: 10.1051/medsci/201329s104. Epub 2013 Mar 13. Med Sci (Paris). 2013. PMID: 23510520 Review. French.
-
[PCR-based diagnosis of mucormycosis in tissue samples].Pathologe. 2013 Nov;34(6):511-8. doi: 10.1007/s00292-013-1831-9. Pathologe. 2013. PMID: 24091920 Review. German.
Cited by
-
Rhino-Orbital Mucormycosis After COVID-19 Recovery: A Case Report.Int Med Case Rep J. 2022 Oct 14;15:579-586. doi: 10.2147/IMCRJ.S379078. eCollection 2022. Int Med Case Rep J. 2022. PMID: 36267194 Free PMC article.
-
Etest cannot be recommended for in vitro susceptibility testing of mucorales.Antimicrob Agents Chemother. 2015;59(6):3663-5. doi: 10.1128/AAC.00004-15. Epub 2015 Apr 6. Antimicrob Agents Chemother. 2015. PMID: 25845881 Free PMC article.
-
Utility of Fluorescent Microscopy for Rapid Intraoperative Diagnosis of Rhinocerebral Mucormycosis: Experience from a Tertiary Care Center in Central India.Cureus. 2025 Mar 31;17(3):e81537. doi: 10.7759/cureus.81537. eCollection 2025 Mar. Cureus. 2025. PMID: 40314049 Free PMC article.
-
Battling the emerging epidemic of rhino-orbital-cerebral mucormycosis (ROCM) in COVID-19 pandemic: an interventional study.Int Ophthalmol. 2023 May;43(5):1571-1580. doi: 10.1007/s10792-022-02556-3. Epub 2022 Oct 23. Int Ophthalmol. 2023. PMID: 36273362 Free PMC article.
-
Molecular diagnosis of rhino-orbital mucormycosis in a COVID-19 setting.Int Ophthalmol. 2023 Jun;43(6):1803-1810. doi: 10.1007/s10792-022-02577-y. Epub 2022 Nov 21. Int Ophthalmol. 2023. PMID: 36414852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous